GODDARD PAUL

CIK 00012271245 companiesEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001227124

Recent Transactions

50 trades

Award
ONYX PHARMACEUTICALS INC
Common Stock
2011-03-31+3,000→ 8,290 total
Award
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2011-03-31+5,000→ 5,000 total
Award
ONYX PHARMACEUTICALS INC
Common Stock
2011-03-31+3,000→ 8,290 total
Award
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2011-03-31+5,000→ 5,000 total
Award
ONYX PHARMACEUTICALS INC
Common Stock
2009-03-31+2,290→ 2,290 total
Award
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2009-03-31+5,726→ 5,726 total
Award
ONYX PHARMACEUTICALS INC
Common Stock
2009-03-31+2,290→ 2,290 total
Award
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2009-03-31+5,726→ 5,726 total
Award
ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2006-02-07+10,000→ 10,000 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.38/sh−171→ 29 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.42/sh−100→ 1,094 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.36/sh−29→ 0 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.44/sh−706→ 1,494 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.43/sh−300→ 1,194 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.50/sh−400→ 6,691 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.46/sh−900→ 2,800 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.51/sh−8,456→ 7,091 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.49/sh−800→ 5,891 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.45/sh−600→ 2,200 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.38/sh−171→ 29 total
Exercise/Conversion
MOLECULAR DEVICES CORP
Non-Employee DirectorStock Option (Right to Buy)
2005-08-23−16,500→ 0 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.39/sh−400→ 200 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.40/sh−494→ 600 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.47/sh−544→ 3,700 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.45/sh−600→ 2,200 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.40/sh−494→ 600 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.42/sh−100→ 1,094 total
Exercise/Conversion
MOLECULAR DEVICES CORP
Non-Employee DirectorStock Option (Right to Buy)
2005-08-23−16,500→ 0 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.54/sh−100→ 16,200 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.39/sh−400→ 200 total
Exercise/Conversion
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$5.25/sh+16,500→ 16,500 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.53/sh−156→ 16,044 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.49/sh−800→ 5,891 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.43/sh−300→ 1,194 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.36/sh−29→ 0 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.55/sh−200→ 16,300 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.52/sh−497→ 15,547 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.48/sh−1,647→ 4,244 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.51/sh−8,456→ 7,091 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.46/sh−900→ 2,800 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.50/sh−400→ 6,691 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.44/sh−706→ 1,494 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.55/sh−200→ 16,300 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.52/sh−497→ 15,547 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.47/sh−544→ 3,700 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.54/sh−100→ 16,200 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.53/sh−156→ 16,044 total
Exercise/Conversion
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$5.25/sh+16,500→ 16,500 total
Sale
MOLECULAR DEVICES CORP
Common Stock
2005-08-23$20.48/sh−1,647→ 4,244 total
Conversion
XENOPORT INC
Series B Convertible Preferred Stock
2005-06-07−1,666→ 0 total

Companies

Recent Filings

Address

C/O ONYX PHARMACEUTICALS, INC. 2100 POWELL ST., 12TH FLOOR

EMERYVILLE, CA, 94608

View on SEC.gov